Kaplan Fox & Kilsheimer LLP Investigates Potential Securities Law Violations Against TransMedics Group, Inc. (™DX) By Investing.com



NEW YORK – January 11, 2025 (NEWMEDIAWIRE) – Kaplan Fox & Kilsheimer LLP is investigating potential securities violations against TransMedics Group (NASDAQ:), Inc. (TransMedics or the Company) (NASDAQ: ™DX).

CLICK HERE TO RECEIVE MORE INFORMATION ABOUT THIS INVESTIGATION

If you are a TransMedics investor and have suffered losses, you can CLICK HERE to contact us. You can also contact Kaplan Fox by emailing [email protected] or by calling (646) 315-9003.

On January 10, 2025, Scorpion Capital published a short report entitled, Walk Like An Egyptian: A Mafia-Style Extortion, Racketeering, And Organ Trafficking Scheme Masquerading And A Medical (TASE:) Device Company Driven by Kickbacks, Billing Fraud, Unreported Device Failures, and Off-Label Use on a Large Scale; Triggering a Customer Exodus And Rapidly Unfolding Death Spiral. Batas (NYSE:) Price: $0 (the Report). The Report alleges, among other things, fraudulent billing schemes, off-label use of its devices, and reliance on kickbacks to drive sales. The Report also alleges that the Company may be under regulatory scrutiny by the US Department of Justice, Internal Revenue Service, and state attorneys general for Medicare fraud related to organ procurement costs.

On this news, TransMedics’ stock price fell $3.74, or 5.16%, to close at $68.81 on January 10, 2025.

WHY CONTACT KAPLAN FOX – Kaplan Fox is a leading national law firm focusing on complex litigation with offices in New York, Oakland, Los Angeles, Chicago and New Jersey. With over 50 years of experience in securities litigation, Kaplan Fox offers the professional experience and track record that clients demand. By prosecuting cases at the federal and state levels, Kaplan Fox has successfully shaped the law by winning many important decisions for our clients. For more information about Kaplan Fox & Kilsheimer LLP, you can visit our website at www.kaplanfox.com.

This press release may be considered Attorney Advertising in some jurisdictions under applicable law and ethical rules.

If you have any questions about this investigation, please contact:

Pamela A. Mayer

KAPLAN FOX & KILSHEIMER LLP

800 Third Avenue, 38th Floor

New York, New York 10022

(646) 315-9003

[email protected]

Laurence D. King

KAPLAN FOX & KILSHEIMER LLP

1999 Harrison Street, Suite 1560

Oakland, California 94612

(415) 772-4704

[email protected]

See the original release at www.newmediawire.com

Copyright 2025 JCN Newswire. All rights reserved.





Source link

  • Related Posts

    ROSEN, RECOGNIZED INVESTOR COUNSEL, Urges Rentokil Initial plc Investors to Secure Advice Ahead of Important Securities Class Action Deadline

    New York, New York–(Newsfile Corp. – January 11, 2025) – WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of American Depositary Shares (“ADS”) of Rentokil Initial…

    This week on Bidenomics: Thanks for nothing, man

    This week on Bidenomics: Thanks for nothing, man Source link

    Leave a Reply

    Your email address will not be published. Required fields are marked *